Investigation of Vascular Pathology in Eye Diseases Using Using Optical Coherence Tomography Angiography (OCT-A)

NCT02811536 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 440

Last updated 2022-11-29

No results posted yet for this study

Summary

Comparison of OCTA to conventional imaging modalities for the diagnosis of eye diseases

Conditions

  • Retinal Disease

Interventions

DEVICE

optical coherence tomography angiography

Imaging with optical coherence tomography angiography

Sponsors & Collaborators

  • Insel Gruppe AG, University Hospital Bern

    lead OTHER

Principal Investigators

  • Martin Zinkernagel, Prof.MD PhD · Inselspital, University Clinic for Ophthalmology

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-02-13
Primary Completion
2022-11-25
Completion
2022-11-25

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02811536 on ClinicalTrials.gov